Methylphenidate for ADHD in Preschoolers

Abstract

The effectiveness of methylphenidate (MPH), 0.3 and 0.5 mg/kg 2x daily, in the treatment of 31 children, aged 4 to 6 years, with attention-deficit hyperactivity disorder (ADHD) was investigated by a double-blind, placebo-controlled study at the University of Ottawa, Canada.

Keywords

• methylphenidate
• attention-deficit hyperactivity disorder
• placebo